IRTC iRhythm Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRTC

Price (delayed)

$121.21

Market cap

$3.66B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.88

Enterprise value

$3.71B

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
The company's gross profit rose by 32% YoY and by 11% QoQ
The revenue has grown by 27% YoY and by 8% from the previous quarter
The company's net income fell by 15% YoY but it rose by 10% QoQ
The EPS has decreased by 12% YoY but it has increased by 10% from the previous quarter
IRTC's equity is down by 14% year-on-year
The debt is up by 11% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.irhythmtech.com
Peers: MD

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
30.22M
Market cap
$3.66B
Enterprise value
$3.71B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
15.22
Price to sales (P/S)
8.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.04
Earnings
Revenue
$410.92M
EBIT
-$111.75M
EBITDA
-$92.14M
Free cash flow
-$52.84M
Per share
EPS
-$3.88
Free cash flow per share
-$1.77
Book value per share
$7.96
Revenue per share
$13.74
TBVPS
$14.95
Balance sheet
Total assets
$448.22M
Total liabilities
$208.41M
Debt
$131.04M
Equity
$239.81M
Working capital
$199.68M
Liquidity
Debt to equity
0.55
Current ratio
3.24
Quick ratio
2.95
Net debt/EBITDA
-0.57
Margins
EBITDA margin
-22.4%
Gross margin
68.5%
Net margin
-28.3%
Operating margin
-27.7%
Efficiency
Return on assets
-26.5%
Return on equity
-48%
Return on invested capital
-27.5%
Return on capital employed
-31.1%
Return on sales
-27.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
1.66%
1 week
7.34%
1 month
3.9%
1 year
-16.48%
YTD
29.4%
QTD
29.4%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$410.92M
Gross profit
$281.63M
Operating income
-$113.78M
Net income
-$116.16M
Gross margin
68.5%
Net margin
-28.3%
The company's gross profit rose by 32% YoY and by 11% QoQ
The revenue has grown by 27% YoY and by 8% from the previous quarter
The net margin is up by 16% from the previous quarter and by 10% YoY
IRTC's operating margin is up by 16% from the previous quarter and by 11% YoY

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
15.22
P/S
8.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.04
The EPS has decreased by 12% YoY but it has increased by 10% from the previous quarter
IRTC's P/B is 24% below its 5-year quarterly average of 20.0 but 2.1% above its last 4 quarters average of 14.9
IRTC's equity is down by 14% year-on-year
The P/S is 29% below the 5-year quarterly average of 12.5 and 10% below the last 4 quarters average of 9.8
The revenue has grown by 27% YoY and by 8% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has decreased by 41% YoY but it has increased by 6% from the previous quarter
The ROA has contracted by 24% YoY but it has grown by 9% from the previous quarter
The ROS has increased by 17% from the previous quarter and by 12% YoY
IRTC's return on invested capital is up by 13% since the previous quarter but it is down by 4.2% year-on-year

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 115% greater than its total liabilities
IRTC's total liabilities is up by 14% YoY and by 3.6% from the previous quarter
The quick ratio has contracted by 9% YoY and by 7% from the previous quarter
The debt is 45% less than the equity
The debt to equity has grown by 31% YoY
IRTC's equity is down by 14% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.